Identification of a novel selective H1-antihistamine with optimized pharmacokinetic properties for clinical evaluation in the treatment of insomnia

Bioorganic & Medicinal Chemistry Letters
2010.0

Abstract

Analogs of the known H(1)-antihistamine R-dimethindene with suitable selectivity for key GPCRs, P450 enzymes and hERG channel were assessed for metabolism profile and in vivo properties. Several analogs were determined to exhibit diverse metabolism. One of these compounds, 10a, showed equivalent efficacy in a rat EEG/EMG model to a previously identified clinical candidate and a potentially superior pharmacokinetic profile as determined from a human microdose study.

Knowledge Graph

Similar Paper

Identification of a novel selective H1-antihistamine with optimized pharmacokinetic properties for clinical evaluation in the treatment of insomnia
Bioorganic & Medicinal Chemistry Letters 2010.0
Characterization of Novel Selective H<sub>1</sub>-Antihistamines for Clinical Evaluation in the Treatment of Insomnia
Journal of Medicinal Chemistry 2009.0
Design, synthesis and biological activity evaluation of desloratadine analogues as H1 receptor antagonists
Bioorganic &amp; Medicinal Chemistry 2013.0
Norpiperidine Imidazoazepines as a New Class of Potent, Selective, and Nonsedative H<sub>1</sub> Antihistamines
Journal of Medicinal Chemistry 2005.0
Benzo- and pyrido-1,4-oxazepin-5-ones and -thiones: synthesis and structure-activity relationships of a new series of H1-antihistamines
Journal of Medicinal Chemistry 1989.0
Structure−Activity Relationships of Dimethindene Derivatives as New M<sub>2</sub>-Selective Muscarinic Receptor Antagonists
Journal of Medicinal Chemistry 2003.0
Synthesis and Structure−Activity Relationships of Novel Histamine H<sub>1</sub> Antagonists:  Indolylpiperidinyl Benzoic Acid Derivatives
Journal of Medicinal Chemistry 2004.0
Synthesis and antihistamine evaluations of novel loratadine analogues
Bioorganic &amp; Medicinal Chemistry Letters 2011.0
Stereoselective synthesis of desloratadine derivatives as antagonist of histamine
Bioorganic &amp; Medicinal Chemistry 2010.0
Identification and profiling of 3,5-dimethyl-isoxazole-4-carboxylic acid [2-methyl-4-((2S,3′S)-2-methyl-[1,3′]bipyrrolidinyl-1′-yl)phenyl] amide as histamine H3 receptor antagonist for the treatment of depression
Bioorganic &amp; Medicinal Chemistry Letters 2013.0